Previous issues

  • HOME
  • BROWSE ARTICLES
  • Previous issue
Volume 25(2); Jun 2024
Opinion
테크놀로지 혁신이 주도하는 당뇨병 진료환경의 변화
강신애
J Korean Diabetes. 2024;25(2):57-61.   Published online June 30, 2024
Statement
1형당뇨병과 2형당뇨병의 혈관합병증, 과연 같을까?
조윤경
J Korean Diabetes. 2024;25(2):62-68.   Published online June 30, 2024
Focused Issues
GLP-1수용체작용제
정승민
J Korean Diabetes. 2024;25(2):69-75.   Published online June 30, 2024
1088
GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로
오태정
J Korean Diabetes. 2024;25(2):76-81.   Published online June 30, 2024
글루카곤 수용체작용제의 기전 및 GLP-1/글루카곤/GIP수용체 삼중 효현제의 효과
민세희
J Korean Diabetes. 2024;25(2):82-88.   Published online June 30, 2024
Information Desks
1090
2024 1형당뇨병 환자 지원을 위한 정책 개정
유재현
J Korean Diabetes. 2024;25(2):89-92.   Published online June 30, 2024
비대면 당뇨병 영양교육
이정숙
J Korean Diabetes. 2024;25(2):93-98.   Published online June 30, 2024
사회생태학적 관점으로 바라본 당뇨병을 갖고 있는 청년의 삶
박유정
J Korean Diabetes. 2024;25(2):99-106.   Published online June 30, 2024
Original Article
1093
2023 대국민 당뇨병 인식 조사 결과
유빈, 임성철, 구미현, 대한당뇨병학회 언론-홍보위원회
J Korean Diabetes. 2024;25(2):107-116.   Published online June 30, 2024

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

  • 5,452 Clinical Nutrition Therapy for Weight Control in Obese Diabetic Patients
    4,837 Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
    1,505 Technological Innovations Transforming Diabetes Care in Practice
    1,411 Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
    2,636 Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning

    +more

    • KoreaMed
    • KoMCI
    • GoogleScholar
    • Similarity Check
    • Crossref Cited-by Linking
    • CrossMark
    • Funder Registry
    • ORCID


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer